ARTICLE | Clinical News
Cytokinetics, GlaxoSmithKline preclinical data
October 27, 2008 7:00 AM UTC
In mouse xenograft models of advanced colon cancer, animals receiving 125 mg/kg of GSK-923295 had a 6% decrease in tumor volume during the first treatment cycle while those receiving 62.5 mg/kg had a ...